)
Company research26 Mar 2024
Companies That Had Their IPO in 1989: The Calm Between the Storms
A look at the IPO landscape and market sentiment in 1989 as the markets enjoyed a period of relative calm between tumultuous times.
Sanofi
Sanofi (SAN) investor relations material
Sanofi Collaboration summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Collaboration summary1 Oct, 2026
Opening remarks and agenda
Expanded a 20-year alliance focused on Type 2 inflammation medicines, building on a track record of collaboration and leadership in atopic dermatitis.
Alliance expansion and strategic objectives
Expanded collaboration adds four next-generation, long-acting antibodies targeting IL-13, IL-4/IL-13, IL-4 receptor alpha, and IL-4, extending the alliance beyond DUPIXENT.
The alliance aims to accelerate innovative therapies for immune-mediated diseases, using established development and global commercial platforms to reach patients.
Partner roles and collaborative capabilities
Regeneron leads development decisions; Sanofi retains final commercial authority, including access and pricing, with Regeneron gaining greater participation in key payer engagements.
Partners combine antibody discovery and immunology expertise with clinical experience, prescriber relationships, patient services, supply capabilities, and global market access.
Programs will advance in parallel, with learnings shared across assets; experience from nine approved DUPIXENT indications may inform trial design and execution.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sanofi
- Rigorous portfolio review and strategic alliances drive innovation and pipeline advancement.SAN
Bank of America Global Healthcare Conference - Strategic focus on specialty care, pipeline rigor, and flexible deal-making drive future growth.SANMorgan Stanley 24th Annual Global Healthcare Conference
- Q2 2026 saw double-digit sales and EPS growth, upgraded guidance, and major pipeline progress.SANQ2 2026
- Pipeline progress, margin expansion, and strategic investments drive future growth.SANMorgan Stanley 23rd Annual Global Healthcare Conference
- 2025 delivered double-digit sales and EPS growth, led by innovation and strong capital returns.SANQ4 2025
- Tolebrutinib delayed disability progression in MS by up to 31% with manageable liver risk.SANStatus Update
- Q3 sales up 16% CER to €13.4B, with upgraded EPS guidance and strong pipeline momentum.SANQ3 2024
- Q1 2025 delivered 9.7% sales growth, 15.7% EPS rise, and confirmed guidance for the year.SANQ1 2025
- Double-digit growth, strong pipeline, and €5bn buyback set up robust 2025 outlook.SANQ4 2024
Next Sanofi earnings date
Q3 202630 Oct, 2026
Sanofi
Next Sanofi earnings date
Q3 202630 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage